Eur J Cancer 2019 Apr 4;113:1-9. Epub 2019 Apr 4.
Aims: The activity that the immune checkpoint inhibitor (ICI) cemiplimab has recently demonstrated has led to a paradigm shift in the management of patients with advanced cutaneous squamous cell carcinoma (cSCC). To identify predictive biomarkers of response to ICIs in advanced cSCC, we studied 33 patients who received ICI therapy at the Dana-Farber/Harvard Cancer Center (DF/HCC) and analysed sequencing data for a subset of these patients.
Oncol Lett 2019 May 19;17(5):4068-4084. Epub 2018 Nov 19.
Department of Pathology, Colentina Clinical Hospital, 020125 Bucharest, Romania.
Int J Surg Pathol 2019 Apr 3:1066896919839143. Epub 2019 Apr 3.
1 Florida Orlando Hospital, Orlando, FL, USA.
Five-year outcome of ultrasound-guided interstitial permanent I seeds implantation for local head and neck recurrent tumors: a single center retrospective study.
J Contemp Brachytherapy 2019 Feb 28;11(1):28-34. Epub 2019 Feb 28.
Department of Radiation Oncology, Peking University Third Hospital, Beijing.
Purpose: The aim of this study was to evaluate the efficacy and safety of interstitial permanent low-dose-rate ultrasound-guided I seeds implantation of local head and neck recurrent tumors.
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial.
Oncologist 2019 Mar 22. Epub 2019 Mar 22.
Background: Anlotinib is a tyrosine kinase inhibitor inhibiting angiogenesis. This multicenter, randomized phase II trial aimed to investigate the efficacy and safety of anlotinib in comparison with sunitinib as first-line treatment for patients with metastatic renal cell carcinoma (mRCC).
Int J Surg Case Rep 2019 7;56:96-100. Epub 2019 Mar 7.
Multidisciplinary Department of Medical and Dental Specialties, Università degli Studi della Campania "Luigi Vanvitelli", Plastic Surgery Unit, Naples, Italy.
Clin Cancer Res 2019 Mar 7. Epub 2019 Mar 7.
Uncommon Presentation of Metastatic Squamous Cell Carcinoma of the Skin and Treatment Challenges.
Am J Case Rep 2019 Mar 6;20:294-299. Epub 2019 Mar 6.
Department of Pathology, Brookdale University Hospital Medical Center, Brooklyn, NY, USA.
Lancet Oncol 2019 Apr 28;20(4):581-590. Epub 2019 Feb 28.
Ann Surg Oncol 2019 Feb 25. Epub 2019 Feb 25.
Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong University, Jinan, Shandong Province, People's Republic of China.
Background: The efficacy, toxicity, and patterns of failure of esophageal squamous cell carcinoma (ESCC) treated with selective lymph node (SLN) conventional fraction radiotherapy (CFRT) and S-1 plus cisplatin (CDDP) were evaluated.
Infrared and Raman Spectroscopic Studies of Molecular Disorders in Skin Cancer.
Aim: To investigate the molecular structural disorders of cancerous skin.
A case of capecitabine-induced dermatomyositis.
Viral genome integration of canine papillomavirus 16.
Papillomavirus Res 2019 Feb 13;7:88-96. Epub 2019 Feb 13.
Department of Pathology, Georgetown University Medical Center, Washington, DC, USA.
Unusual Sites of Metastatic and Benign I 131 Uptake in Patients with Differentiated Thyroid Carcinoma.
Department of Nuclear Medicine and Molecular Imaging, Amrita Institute of Medical Sciences, Amrita Vishwavidyapeetham, Cochin, Kerala, India.
Effects of thoracic epidural anesthesia/analgesia on the stress response, pain relief, hospital stay, and treatment costs of patients with esophageal carcinoma undergoing thoracic surgery: A single-center, randomized controlled trial.
Department of Anesthesiology, The first affiliated hospital of Nanjing Medical University, Nanjing, 210029, China.
Background: Appropriate postoperative pain management can improve outcomes in patients with esophageal cancer (EC).
Objective: To compare different combinations of anesthesia and analgesia techniques in patients with EC undergoing open thoracotomy.
Multiple cutaneous metastasis of synchronous urothelial carcinoma of the bladder and the renal pelvis: a case report.
J Med Case Rep 2019 Feb 14;13(1):34. Epub 2019 Feb 14.
Surgical Oncology Department, Institute Salah Azaiez de Cancer, Tunis, Tunisia.
Introduction: Cutaneous metastatic disease arising from urinary tract carcinoma is rare and associated with a poor prognosis. We report a case of metastatic disease occurring in a patient treated for synchronous urothelial tumor of the bladder and left renal pelvis.
Diagnosis and Management of Basal Cell Carcinoma.
Curr Treat Options Oncol 2019 Feb 11;20(2):13. Epub 2019 Feb 11.
Department of Dermatology, Keio University School of Medicine, Shinanomachi 35, Shinjuku, Tokyo, 160-8582, Japan.
Department of Pathology, Laboratório Bacchi, Botucatu (SP), Brazil.
Hand-Foot Syndrome and Progression-Free Survival in Patients Treated with Sunitinib for Metastatic Clear Cell Renal Cell Carcinoma.
Department of Uro-Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.